Price Chart


Price Chart

Profile

Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.
URL http://www.nanosonics.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Aug. 27, 2026 (est.)
Last Earnings Release Feb. 24, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.
URL http://www.nanosonics.com.au
Investor Relations URL N/A
HQ State/Province New South Wales (NSW)
Sector Health Care
Industry Health Care Equipment & Supplies
Next Earnings Release Aug. 27, 2026 (est.)
Last Earnings Release Feb. 24, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A